NEOSYNEPHRINE 1% phenylephrine hydrochloride 10mg/1mL injection USP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

neosynephrine 1% phenylephrine hydrochloride 10mg/1ml injection usp ampoule

pfizer australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate dihydrate; sodium metabisulfite; nitrogen; sodium chloride; citric acid - indications as at 01 jan 1991 : phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, of hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anesthesia, and as a vasoconstrictor in regional analgesia.

PAPAVERINE TEVA INJECTION Israel - English - Ministry of Health

papaverine teva injection

teva israel ltd - papaverine hydrochloride - solution for injection - papaverine hydrochloride 40 mg / 2 ml - papaverine - papaverine - antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. peripheral vascular disease with vasospastic element. vascular spasm associated with acute myocardial infarcion, angina pectoris, peripheral and pulmonary embolism.

SCANDONEST 3% WITHOUT VASOCONSTRICTOR Israel - English - Ministry of Health

scandonest 3% without vasoconstrictor

a. levy dental co. ltd, israel - mepivacaine hydrochloride - solution for injection - mepivacaine hydrochloride 30 mg / 1 ml - mepivacaine - mepivacaine - for the local and loco-regional anaesthesia in dental surgery in adults, adolescents and children above 4 years of age (c.a. 20 kg of body weight).

SANDOMIGRAN pizotifen 0.5mg (as malate) tablet    bottle Australia - English - Department of Health (Therapeutic Goods Administration)

sandomigran pizotifen 0.5mg (as malate) tablet bottle

aft pharmaceuticals pty ltd - pizotifen malate, quantity: 0.725 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; povidone; acacia; purified talc; sucrose; lactose monohydrate; cetyl palmitate; magnesium stearate; maize starch; titanium dioxide - indications as at 14 june 2004: prophylactic (interval) treatment of vascular headaches: typical and atypical migraine, vasomotor headache, cluster headache (horton's syndrome). sandomigran is without effect in the migraine attack. for this purpose preparations containing ergotamine are recommended.

XYRALID HEMORRHOIDAL- hemorrhoidal suppositories suppository United States - English - NLM (National Library of Medicine)

xyralid hemorrhoidal- hemorrhoidal suppositories suppository

innovus pharmaceuticals, inc. - active ingredients purpose, cocoa butter 88.50%...................................................................protectant, phenylephrine hydrochloride 0.26%..............................................vasoconstrictor - - temporarily shrinks hemorrhoidal tissue - temporarily relieves itching, burning, and discomfort associated with hemorrhoids - aids in protecting irritated anorectal areas ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression -heart disease    -high blood pressure -thyroid disease   -diabetes -difficulty in urination due to enlargement of the prostate gland bleeding occurs or condition worsens or does not improve within 7 days protectant vasoconstrictor

PHENYLIP phenylephrine hydrochloride 10 mg / 1 mL injection USP vial Australia - English - Department of Health (Therapeutic Goods Administration)

phenylip phenylephrine hydrochloride 10 mg / 1 ml injection usp vial

cipla australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg - injection - excipient ingredients: water for injections; sodium chloride; sodium citrate dihydrate; citric acid monohydrate; sodium metabisulfite; hydrochloric acid; sodium hydroxide - phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia.

NORVASC 10 MG TABLETS Israel - English - Ministry of Health

norvasc 10 mg tablets

pfizer pfe pharmaceuticals israel ltd - amlodipine as besylate - tablets - amlodipine as besylate 10 mg - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

NORVASC 5 MG TABLETS Israel - English - Ministry of Health

norvasc 5 mg tablets

pfizer pfe pharmaceuticals israel ltd - amlodipine as besylate - tablets - amlodipine as besylate 5 mg - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.